Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $16,274 | $49,132 | $337,906 | $270,152 |
| - Cash | $25,451 | $59,537 | $107,146 | $60,437 |
| + Debt | $1,666 | $3,040 | $6,718 | $8,196 |
| Enterprise Value | -$7,511 | -$7,365 | $237,478 | $217,911 |
| Revenue | $0 | $9,750 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$1,385 | $8,316 | -$1,870 | -$1,845 |
| % Margin | – | 85.3% | – | – |
| EBITDA | -$38,265 | -$113,654 | -$88,267 | -$88,015 |
| % Margin | – | -1,165.7% | – | – |
| Net Income | -$18,866 | -$115,088 | -$88,523 | -$86,346 |
| % Margin | – | -1,180.4% | – | – |
| EPS Diluted | -7.94 | -31.16 | -26.2 | -36.5 |
| % Growth | 74.5% | -18.9% | 28.2% | – |
| Operating Cash Flow | -$43,608 | -$66,300 | -$84,312 | -$78,745 |
| Capital Expenditures | -$133 | -$147 | -$61 | -$7 |
| Free Cash Flow | -$43,741 | -$66,447 | -$84,373 | -$78,752 |